Bob Bradway — SPARQNOW

At-a-Glance

Serves as Chairman and Chief Executive Officer at Amgen, a biotechnology company with over $28 billion in sales and 27,000 employees.
Led Amgen to become one of the 30 companies included in the Dow Jones Industrial Average in August 2020.
Spent nearly two decades as an investment banker at Morgan Stanley, primarily working with healthcare clients.
Holds an MBA and a Bachelor's degree in Biology.

Biography

Bob Bradway is the Chairman and Chief Executive Officer of Amgen, a position he has held since 2013 and 2012, respectively. He joined Amgen in 2006, starting in Operations, before becoming Chief Financial Officer in 2007 and President and Chief Operating Officer in 2010. Under his leadership, Amgen has grown into one of the largest biotechnology companies globally, with 2023 sales exceeding $28 billion and approximately 27,000 employees.